Aims and Scope of Expert Opinion on Biological Therapy
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974. The journal is also indexed in MEDLINE. Less
Key Metrics
CiteScore 

7.2
Eigenfactor 

0.005 - 0.01
H-Index 

96
Impact Factor 

< 5
SJR 

Q1Pharmacology

SNIP 

1.01
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Opinion on Biological Therapy
Expert Opinion on Biological Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Biological Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Opinion on Biological Therapy
Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis
- 29 Jun 2026
- Expert Opinion on Biological Therapy
Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering—an expert perspective
- 28 Jun 2026
- Expert Opinion on Biological Therapy
Comparative overview of biosimilar regulatory frameworks and international harmonization trends
- 20 Jun 2026
- Expert Opinion on Biological Therapy
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study
- 4 Jun 2026
- Expert Opinion on Biological Therapy
Type 2 inflammation and biologics: a twenty-year journey
- 3 Jun 2026
- Expert Opinion on Biological Therapy
Biological drugs for the treatment of children with atopic dermatitis
- 3 Jun 2026
- Expert Opinion on Biological Therapy
Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis
- 29 Jun 2026
- Expert Opinion on Biological Therapy
Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering—an expert perspective
- 28 Jun 2026
- Expert Opinion on Biological Therapy
Comparative overview of biosimilar regulatory frameworks and international harmonization trends
- 20 Jun 2026
- Expert Opinion on Biological Therapy
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study
- 4 Jun 2026
- Expert Opinion on Biological Therapy
Type 2 inflammation and biologics: a twenty-year journey
- 3 Jun 2026
- Expert Opinion on Biological Therapy
Biological drugs for the treatment of children with atopic dermatitis
- 3 Jun 2026
- Expert Opinion on Biological Therapy